Exploring new pathways in endocrine-resistant breast cancer

The most common breast cancer (BC) subtypes are hormone-dependent, being either estrogen receptor-positive (ER(+)), progesterone receptor-positive (PR(+)), or both, and altogether comprise the luminal subtype. The mainstay of treatment for luminal BC is endocrine therapy (ET), which includes several...

Descripción completa

Detalles Bibliográficos
Autores principales: de Pinho, Inês Soares, Abreu, Catarina, Gomes, Inês, Casimiro, Sandra, Pacheco, Teresa Raquel, de Sousa, Rita Teixeira, Costa, Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400750/
https://www.ncbi.nlm.nih.gov/pubmed/36045911
http://dx.doi.org/10.37349/etat.2022.00086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400750/
https://www.ncbi.nlm.nih.gov/pubmed/36045911
http://dx.doi.org/10.37349/etat.2022.00086

Ejemplares similares